Article Information
History
- March 17, 2021.
Article Versions
- You are currently viewing Version 1 of this article (March 17, 2021 - 05:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Rahul Y. Mahida1,*,†,
- Aaron Scott1,*,
- Dhruv Parekh1,
- Sebastian T. Lugg1,
- Rowan S. Hardy2,
- Gareth G. Lavery2,
- Michael A. Matthay3,
- Babu Naidu1,
- Gavin D. Perkins4,⍰ and
- David R. Thickett1,⍰
- 1Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, U.K.
- 2Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, U.K.
- 3Cardiovascular Research Institute, Department of Medicine, and Department of Anaesthesia, University of California San Francisco, San Francisco, California, U.S.A.
- 4Emergency, Pre-hospital, Perioperative and Critical Care Group, Warwick Medical School, University of Warwick, Warwick, U.K.
- ↵†Corresponding Author: Dr Rahul Y. Mahida, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, B15 2TH, U.K., Email: r.mahida{at}bham.ac.uk
Posted March 17, 2021.
Acute Respiratory Distress Syndrome is associated with impaired alveolar macrophage efferocytosis
